Stereotactic Ablative Radiation Therapy for Oligoprogressive Metastatic RCC: Predictors of Prolonged Benefit from Ongoing Systemic Therapy
Fields of Study & Subjects
Hepatocellular Carcinoma Treatment and Prognosis
Brain Metastases and Treatment
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Volume
- 125
- Issue
- 5
- Pages
- 1456–1465
- Publication date
- 14 February 2026
- Language
- EN